In the relentless battle against lung cancer, early detection remains a cornerstone strategy to improve survival rates. A recent prospective study sheds new light on a critical, yet often overlooked dimension of lung cancer screening: the patient experience. Led by Dr. Jessica H. Porembka from the University of Texas Southwestern Medical Center, this investigation delves deeply into the physical and emotional toll of low-dose chest computed tomography (CT) screening among a diverse cohort of lung cancer screening participants. The study’s findings, published in the Journal of the American College of Radiology, reveal significant socioeconomic disparities in the screening experience, underscoring an urgent need for tailored interventions to enhance both adherence and equity.
Lung cancer continues to claim more lives in the United States than any other cancer, with survival closely tied to the stage at diagnosis. Low-dose chest CT screening has emerged as a powerful diagnostic tool, capable of detecting lung cancer at its earliest stages when treatment is most effective. Despite its proven clinical benefits, widespread adoption and consistent annual participation in lung cancer screening programs remain disappointingly limited. Researchers have speculated that beyond clinical outcomes, patient comfort and anxiety related to the screening process might influence adherence, potentially contributing to these moderate uptake rates.
Addressing this knowledge gap, Dr. Porembka and her interdisciplinary team designed a robust, prospective study enrolling 468 individuals participating in lung cancer screening across two distinct healthcare environments: a university health system and a county safety-net system serving economically disadvantaged and marginalized populations. Utilizing rigorously validated patient-reported outcome measures, the investigators sought to quantify the subjective physical discomfort and emotional anxiety associated with the low-dose chest CT experience. Their goal was to elucidate how social determinants of health and healthcare context interplay with patient perceptions of screening burden.
The overall testing-related burden reported by participants was low, suggesting that the low-dose chest CT exam itself is generally well tolerated. Nonetheless, a noteworthy subset of participants recounted significant discomfort or anxiety linked to the screening experience. Particularly striking were disparities observed in the safety-net population, who reported higher incidences of pain or discomfort both prior to and during the CT procedure. These results indicate that socioeconomic context and healthcare setting deeply influence patient experience, a crucial consideration for screening program design.
Advanced multivariable statistical analysis illuminated complex relationships between social factors and screening-related burden. Variables including marital status, employment, and type of insurance coverage were significantly correlated with increased physical and emotional distress. Such associations point to a broader systemic challenge: individuals facing socioeconomic disadvantages may encounter heightened barriers to comfortable and anxiety-free screening experiences, which could ultimately deter continued participation necessary for effective lung cancer surveillance.
This study marks a pivotal step toward integrating patient-centered metrics within lung cancer screening research. Historically, investigations have largely focused on quantifiable clinical metrics—tumor size, staging accuracy, survival rates—while neglecting the patient’s subjective journey through the screening process. By applying validated instruments to capture nuanced dimensions of physical discomfort and emotional state, the research highlights previously unrecognized nuances in patient experience that are critical for optimizing screening adherence and outcomes.
Moreover, Dr. Porembka emphasizes that lung cancer screening is only life-saving if patients adhere to annual testing protocols. The study suggests that even transient episodes of pain or anxiety—if unaddressed—could cumulatively discourage repeat screening, undermining the screening program’s long-term effectiveness. Such findings resonate with broader public health concerns about patient retention and screening adherence in preventive medicine.
Importantly, the research opens avenues for targeted interventions aimed at reducing the burden of screening. Strategies to alleviate pre-test anxiety, such as patient education and relaxation techniques, could substantially improve emotional well-being. Additionally, addressing physical discomfort through optimized scanning protocols and supportive care during the procedure may enhance the overall patient experience. Importantly, dismantling structural and systemic barriers prevalent in underserved settings remains critical to delivering equitable cancer screening.
The implications extend beyond lung cancer. This study exemplifies the imperative to center patient experience and social determinants of health in the design and implementation of screening modalities across medicine. As health disparities gain increasing attention, incorporating such patient-reported outcomes into clinical workflows can help identify and mitigate inequities, fostering more inclusive and effective healthcare delivery systems.
Co-investigator and Editor-in-Chief of the Journal of the American College of Radiology, Dr. Ruth Carlos of Columbia University, highlights the dual nature of the findings—on one hand, the reassurance that low-dose CT is not inherently burdensome for most patients; on the other, a call to action to address the socioeconomic factors that modulate patient experience. This nuanced understanding advocates for a shift towards more patient-centered, equity-conscious screening programs that acknowledge and accommodate the diverse realities of patients’ lives.
Funded by Canon Medical Systems USA, Inc. through a Radiological Society of North America Research Seed Grant and the Cancer Prevention and Research Institute of Texas, this research represents a collaborative effort to refine lung cancer screening from a technical procedure into a holistic, patient-sensitive intervention. Future research will be critical in developing and testing precise interventions based on these insights, ultimately enhancing adherence and saving more lives through optimized early detection.
The study’s rigorous survey methodology and diverse participant sampling set a new standard in assessing the intersection of diagnostic imaging and social determinants of health. The findings emphasize that lung cancer screening programs must move beyond a uniform clinical perspective and embrace complexity in patient experience, considering emotional, physical, and socioeconomic dimensions to maximize success.
This research also prompts the healthcare community to reconsider communication strategies around lung cancer screening. Transparent, empathetic dialogue addressing potential discomfort and anxiety, along with proactive support systems, could help destigmatize and normalize the screening process. Elevating patient voices and experiences is essential in building trust and engagement, especially within populations historically marginalized in healthcare.
In summary, this landmark study reveals that while low-dose chest CT scans are generally well tolerated, patient experiences vary significantly across socioeconomic lines, affecting screening-related burden. Recognizing and addressing these disparities through patient-centered, equity-driven approaches will be vital for improving long-term adherence and reducing lung cancer mortality. As lung cancer screening programs evolve, integrating these insights will be crucial to fostering accessible, effective, and compassionate preventive care.
Subject of Research: People
Article Title: Patient-Reported Testing Burden of Low-Dose Chest CT Among Lung Cancer Screening Participants
News Publication Date: June 24, 2026
Web References:
Journal of the American College of Radiology article
References:
Porembka JH, et al. Patient-Reported Testing Burden of Low-Dose Chest CT Among Lung Cancer Screening Participants. J Am Coll Radiol. 2026.
Keywords: Lung cancer, Computerized axial tomography, Diagnostic imaging, Preventive medicine, Health disparity, Health care delivery, Patient monitoring
